Skip to Content

Hengan International Group Co Ltd 01044

Rating as of

Morningstar’s Analysis

Currency in HKD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Price Competition Hurts Hengan's Profits; Competition May Ease, but Higher Costs to Kick In

Jeanie Chen Senior Equity Analyst

Analyst Note

| Jeanie Chen |

No-moat Hengan's first-half results were disappointing, with sales and operating profits down 8.7% and 20%, respectively. Intensified price competition depressed the top line and gross margins while consumers’ channel shift continued to damp sales at the brick-and-mortar channel, Hengan’s strength. We expect cost inflation will weigh on margins but ease price competition into the second half. Additionally, tightened competition rules of online channels could reduce discounting. We have cut our 2021 profit forecasts by 9% to reflect the first-half weakness and higher input costs. The adjustments were largely offset by the increased time value of money, leaving an immaterial impact on our HKD 73 fair value estimate. Concerns about raw material cost inflation and price competition might continue to weigh on the share price until we see the negative impacts dissipate.

Read Full Analysis

Company Profile

Business Description

Founded in 1985, Hengan International is a leading health and hygiene product manufacturer in China. Its business comprises tissue paper products (47% of sales), sanitary napkins (34% of sales), disposable diapers (11% of sales), and others.

Hengan Industrial City, Anhai Town
Jinjiang, 362261, China, People's Republic of
T +86 59585708888
Sector Consumer Defensive
Industry Household & Personal Products
Most Recent Earnings
Fiscal Year End Dec 31, 2020
Stock Type
Employees 23,000

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.